A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer - Wikidata - wikimedia - TriplyDB

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

http://www.wikidata.org/entity/Q28297827

about

Comparison of EndoPredict and Oncotype DX test results in hormone receptor positive invasive breast cancer Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer model Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test A population-based gene signature is predictive of breast cancer survival and chemoresponse A breast cancer prognostic signature predicts clinical outcomes in multiple tumor types New perspectives for in vitro risk assessment of multiwalled carbon nanotubes: application of coculture and bioinformatics Individualized survival and treatment response predictions in breast cancer patients: involvements of phospho-EGFR and phospho-Her2/neu proteins Multiwalled carbon nanotube-induced gene signatures in the mouse lung: potential predictive value for human lung cancer risk and prognosis Confirmation of gene expression-based prediction of survival in non-small cell lung cancer Hybrid models identified a 12-gene signature for lung cancer prognosis and chemoresponse prediction Multiplicities in cancer research: ubiquitous and necessary evils Interpretation of microarray data in cancer Proinvasion metastasis drivers in early-stage melanoma are oncogenes.TSPYL5 suppresses p53 levels and function by physical interaction with USP7 A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial Breast cancer in the personal genomics era Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection Molecular biology of lung cancer: clinical implications BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes Comprehensive molecular portraits of human breast tumours Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with potential diagnostic and prognostic value in human breast cancer MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype Inter- and intra-combinatorial regulation by transcription factors and microRNAs Gene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancer Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II disease How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas Show me the genes - I will tell you who/how to treat!Gene expression profiling predicts survival in conventional renal cell carcinoma.Adjuvant systemic therapy in older women with breast cancer Targeted therapies with companion diagnostics in the management of breast cancer: current perspectives Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer Molecular Imaging of Biomarkers in Breast Cancer "OMIC" tumor markers for breast cancer: A review Breast cancer intrinsic subtype classification, clinical use and future trends

P2860

Q21089802-14A0FBD0-2509-4E6B-9CA4-038940753E4E Q21090788-52024B1F-61C0-483B-B534-BF4FD72EFD7D Q21202033-CE5AAE6D-79F6-4E9C-B697-76CC96833AFD Q21261272-2926CF4C-D540-467B-8739-DB2FF6B75669 Q23909226-5DA353A3-8031-4032-A0C7-5C09695D51D5 Q23909227-7159FA5D-7DBC-465F-9BAE-50D0B42BD459 Q23910479-78AB90D5-07E6-410E-AEB3-B8387E9BD383 Q23916643-0FC60A1A-38C3-4D3A-9EAD-C5AD28BFA632 Q23918758-06912D52-900D-401F-8189-DA4C2B371EA7 Q23918759-6BFBBDAC-F997-4AAE-A23D-D7F077636B15 Q23924046-63AC68D3-D109-450B-8692-887C1D97A0F9 Q24289181-3E246C64-353C-4824-AADB-0872BF7FD95C Q24289307-2CE4F579-605A-4635-BE89-FC261C5454A3 Q24312173-04DDDD43-2EF2-4123-8269-2F11E8E62608 Q24317937-F4577C59-3E9E-4FA1-9342-15EFC1B37A5D Q24569630-C497E256-5EB5-46C3-AF12-2C9DED3673CF Q24597424-90E67979-DE99-4211-A1EF-7D854186B11B Q24597456-878FA41E-D8DB-4FDB-92BE-25B2D93B5D02 Q24602679-5E253568-73E2-4D3C-8301-AB978322C0FF Q24605762-DFFA2F44-C8C5-429B-B89D-11A99C1A74B4 Q24610335-58FAF756-712D-45A2-8EA3-AB470543F7D1 Q24610409-8B705920-9E84-4CF8-98C6-5CF77BB279FB Q24630783-601530EF-F036-4A55-81F7-B65575977C49 Q24630844-F1158950-AF94-498F-8CAE-88A7E68FC12D Q24632628-699455DA-E4AD-441B-A1D7-FE0EAC80B103 Q24646090-75DCA31F-47E2-4779-9C45-323DD579B438 Q24649664-51EFE982-041E-4EFC-87CB-301BA860C195 Q24652481-6786DDD1-35E6-4430-B15E-42566B9CA3AA Q24653339-9F602B78-2E6A-4ECF-9A77-A014F7058E93 Q24655384-1F820432-31C9-4D90-A10F-D8F64EA54989 Q24658523-AE40AA8B-D813-47F6-8ADA-38F7D079600D Q24685605-58D61DF6-8FBF-4CDE-B014-014856DCDB53 Q24797284-5653E327-2F85-45BF-BA2B-4BBCDA78A683 Q24814730-94382F45-3244-4E7C-A0C1-15F0438EB48C Q26741523-EB2813B7-EB7B-4E99-BF62-7C16401DC704 Q26768119-CA0C168A-0204-48D2-9378-712B3E674747 Q26772868-0CB443E2-0D5C-4F09-A32D-2B9FE322EE02 Q26772870-4A6F10B5-79D6-478F-8A6A-27BEAC673005 Q26773092-57E37160-29A7-455B-9940-D45E112D1C53 Q26773761-ED7C9DB7-7C6D-4589-BE36-FFDFDD552D35

P2860

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

http://www.wikidata.org/entity/Q28297827

description

2004 nî lūn-bûn

@nan

2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

@ast

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

@en

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

@nl

type

label

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

@ast

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

@en

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

@nl

prefLabel

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

@ast

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

@en

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

@nl

P1433

Q28297827-920D4A85-CE7B-42B4-B00E-4FE01382AAE2

P1476

Q28297827-B07702C0-5F86-4A9C-A4DE-DFE438A04870

P2093

Q28297827-060EB046-B64A-43A2-B7CE-A90B668994F2

Q28297827-117D16F3-0E68-4DAE-B378-58690F08F356

Q28297827-11C8692B-BF0B-485C-A24D-DB6F7D34159E

Q28297827-39029710-6609-4F2F-B30B-D3ABBEA741B6

Q28297827-3D5D88C3-A9F5-4AE5-9AC4-6BFFD92E4497

Q28297827-4EB2BF76-4D09-4F6C-B9B1-97D290A1B207

Q28297827-57C13F9C-4242-46D5-95E2-C0A4778E7D0F

Q28297827-6042FB08-1BB2-4E3B-B7A0-398A9B7254C1

Q28297827-87CAC9E0-6255-4EB9-AB66-B9B431E4C7DD

Q28297827-AB8C4BA3-452A-4590-91C1-0C39C2E32D3C

P304

Q28297827-DE9D9EBA-B0B4-45CA-B273-9CBF20B7D615

P31

Q28297827-1F6743B5-5503-45F9-AA55-04C290B0AE3C

P3181

Q28297827-6D1BD10A-E60C-44C1-905C-863713B35051

P356

Q28297827-B093FB6E-05B2-4A14-A233-4AD61A7E4406

P407

Q28297827-29A0C37D-4BDF-4479-9728-FCE313DDA223

P433

Q28297827-07F637E2-5197-4B70-8BA3-180CDE5A5FD3

P478

Q28297827-5BADAC58-1270-47B2-B8BF-6226420E7782

P50

Q28297827-80BCDE3C-36AB-4833-92C3-0D4DCFCB8384

Q28297827-B4361626-2483-480D-A49A-869FEE1EE4F5

P577

Q28297827-1B8AD4A1-4799-4167-8A52-F5F66AD6E1D6

P698

Q28297827-958E9E8E-9A26-4F62-B4CA-12790F3E7A10

P921

Q28297827-C17AEDFF-DC8E-4540-9CE9-C120BA4DF438

P3181

P356

P1433

The New England Journal of Medicine

P1476

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

@en

P2093

D Lawrence Wickerham

http://www.w3.org/2001/XMLSchema#string

Drew Watson

http://www.w3.org/2001/XMLSchema#string

Edwin R Fisher

http://www.w3.org/2001/XMLSchema#string

Frederick L Baehner

http://www.w3.org/2001/XMLSchema#string

Gong Tang

http://www.w3.org/2001/XMLSchema#string

Joffre Baker

http://www.w3.org/2001/XMLSchema#string

John Bryant

http://www.w3.org/2001/XMLSchema#string

Maureen Cronin

http://www.w3.org/2001/XMLSchema#string

Michael G Walker

http://www.w3.org/2001/XMLSchema#string

Norman Wolmark

http://www.w3.org/2001/XMLSchema#string

P304

2817-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

150996

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA041588

http://www.w3.org/2001/XMLSchema#string

P407

P433

27

http://www.w3.org/2001/XMLSchema#string

P478

351

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15591335

http://www.w3.org/2001/XMLSchema#string

P921